|
|
Volumn 96, Issue 19, 2004, Pages 1480-1481
|
|
Re: Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer (multiple letters) [2]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLODRONIC ACID;
PAMIDRONIC ACID;
PLACEBO;
ZOLEDRONIC ACID;
BISPHOSPHONIC ACID DERIVATIVE;
IMIDAZOLE DERIVATIVE;
ANEMIA;
BONE METASTASIS;
BONE PAIN;
CANCER SURVIVAL;
CLINICAL TRIAL;
DRUG EFFICACY;
EDEMA;
FATIGUE;
FEVER;
FLU LIKE SYNDROME;
HUMAN;
LETTER;
LONG TERM CARE;
MALE;
MYALGIA;
PRIORITY JOURNAL;
PROSTATE CANCER;
QUALITY OF LIFE;
RATING SCALE;
SCORING SYSTEM;
SIDE EFFECT;
STATISTICAL ANALYSIS;
STATISTICAL SIGNIFICANCE;
WEIGHT REDUCTION;
BONE TUMOR;
CONTROLLED CLINICAL TRIAL;
METABOLISM;
METASTASIS;
NOTE;
OSTEOLYSIS;
PATHOLOGY;
PROSTATE TUMOR;
TREATMENT OUTCOME;
BONE NEOPLASMS;
BONE RESORPTION;
CONTROLLED CLINICAL TRIALS;
DIPHOSPHONATES;
HUMANS;
IMIDAZOLES;
MALE;
PROSTATIC NEOPLASMS;
TREATMENT OUTCOME;
|
|
EID: 7244253125
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/djh294 Document Type: Letter |
|
Times cited : (9)
|
|
References (0)
|
